- $6.14bn
- $5.72bn
- $554.46m
- 98
- 18
- 84
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 322 | 363 | 411 | 490 | 554 |
Cost of Revenue | |||||
Gross Profit | 252 | 284 | 322 | 387 | 447 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 249 | 266 | 323 | 359 | 391 |
Operating Profit | 72.3 | 96.7 | 87.7 | 131 | 163 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 80 | 102 | 89.4 | 134 | 179 |
Provision for Income Taxes | |||||
Net Income After Taxes | 69.3 | 91.6 | 71 | 108 | 152 |
Net Income Before Extraordinary Items | |||||
Net Income | 69.3 | 91.6 | 71 | 108 | 152 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 69.3 | 91.6 | 71 | 108 | 152 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.73 | 2.24 | 1.77 | 2.74 | 4.03 |